Clinical trials
Phase 1 Non-alcoholic Fatty Liver Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sunshine Lake Pharma Co., Ltd. | 3 |
| Gannex Pharma Co., Ltd. | 2 |
| Xiamen Amoytop Biotech Co., Ltd. | 2 |
| Xuanzhu Biopharmaceutical Co., Ltd. | 2 |
| Changchun Intellicrown Pharmaceutical Co. LTD | 1 |
| Guangdong Raynovent Biotech Co., Ltd | 1 |
| Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 1 |
| Kylonova (Xiamen) Biopharma co., LTD. | 1 |
| Nanchang University | 1 |
| Novo Nordisk A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 19 |
| Hyperlipidemias | 2 |
| Obesity | 2 |
| Diabetes Mellitus | 1 |
| Dyslipidemias | 1 |
| Hepatitis B, Chronic | 1 |
| Inflammation | 1 |
| Overweight | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.